Immuron (IMRN) Common Equity (2016 - 2025)
Immuron (IMRN) recorded quarterly Common Equity of $80318.3 in Q3 2025, down 98.45% quarter-over-quarter from $5.2 million in Q2 2025, and down 36.8% on a YoY basis from $127094.4 in Q3 2024.
Immuron (IMRN) Common Equity (2016 - 2025) Analysis & Trends
Immuron's Common Equity history runs 10 years deep, the most recent figure standing at $80318.3 for Q3 2025.
- In Q3 2025, Common Equity fell 36.8% year-over-year to $80318.3; the TTM figure through Sep 2025 stood at $80318.3 (down 36.8% YoY), while the FY2025 annual figure was $80318.3, down 36.8% from the prior year.
- Common Equity was $80318.3 for Q3 2025 at Immuron, down from $5.2 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $19.9 million in Q2 2021 to a low of $80318.3 in Q3 2025.
- Historically, Common Equity has averaged $9.5 million across 5 years, with a median of $10.6 million in 2024.
- The sharpest annual moves came in 2021 and 2023: Common Equity soared 6541.63% in 2021, then slumped 99.25% in 2023.
- A 5-year view of Common Equity shows it stood at $19.0 million in 2021, then decreased by 19.66% to $15.2 million in 2022, then plunged by 99.25% to $114095.9 in 2023, then surged by 5826.24% to $6.8 million in 2024, then slumped by 98.81% to $80318.3 in 2025.
- The last three Common Equity figures came in at $80318.3 (Q3 2025), $5.2 million (Q2 2025), and $6.8 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | 80,318.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 80,318.33 |
| Jun 30, 2025 | 5.17 Mn |
| Dec 31, 2024 | 6.76 Mn |
| Sep 9, 2024 | 127,094.44 |
| Jun 30, 2024 | 8.38 Mn |
| Dec 31, 2023 | 114,095.94 |
| Sep 28, 2023 | 12.86 Mn |
| Aug 30, 2023 | 196,168.36 |
| Jun 30, 2023 | 13.11 Mn |
| Dec 31, 2022 | 15.23 Mn |
| Aug 31, 2022 | 16.12 Mn |
| Jun 30, 2022 | 16.60 Mn |
| Dec 31, 2021 | 18.96 Mn |
| Jun 30, 2021 | 19.94 Mn |
| Dec 31, 2020 | 285,406.46 |
| Sep 1, 2020 | 5.64 Mn |
| Jun 30, 2020 | 3.70 Mn |
| Dec 31, 2019 | 56,439.13 |
| Jun 30, 2019 | 5.15 Mn |
| Dec 31, 2018 | 8.44 Mn |